Becton Dickinson Q2 Revenues Up 5 Percent | GenomeWeb

This article has been updated to include comments from BD's earnings call.

NEW YORK (GenomeWeb) – Becton Dickinson reported today that its fiscal second quarter revenues rose 5 percent year over year.

For the three months ended March 31, the Franklin Lakes, New Jersey-based company posted revenues of $3.07 billion compared to $2.05 billion in the year-ago quarter, in line with analysts' average estimate.

On an adjusted, currency-neutral basis Q2 revenues rose 55 percent year over year, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV. 

Mar
09
Sponsored by
Bio-Rad

This webinar will discuss how next-generation sequencing and digital PCR can be used in a complementary manner for liquid biopsies in order to improve patient care.